𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-1α synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity

✍ Scribed by Wei-Dong Yu; Ming-Jei Chang; Donald L. Trump; C. S. Johnson

Book ID
105968217
Publisher
Springer-Verlag
Year
1997
Tongue
English
Weight
147 KB
Volume
44
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The synergistic antitumor effect of reco
The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice
✍ Takehisa Harada; Norimichi Kan; You Ichinose; Yoshio Moriguchi; Li Li; Tomoharu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

## Abstract Intraperitoneal (i. p.) treatment of MOPC104E ascitic tumor‐bearing BALB/c mice with interleukin‐1 (IL‐1) followed by a low dose of cyclophosphamide (CPA) resulted in synergistic prolongation of their survival time. This antitumor effect was abolished when administration of CPA preceded

Differentiating and antitumor activities
Differentiating and antitumor activities of 1α,25-dihydroxyvitamin D3 in vitro and 1α-hydroxyvitamin D3 in vivo on human osteosarcoma
✍ Dr. Hiroyuki Tsuchiya; Hajime Morishita; Katsuro Tomita; Yoshimichi Ueda; Motohi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 813 KB

## Abstract The differentiating and antitumor activities of 1α,25‐dihydroxyvitamin D~3~ (1α,25(OH)~2~D~3~) in vitro and 1α‐hydroxyvitamin D~3~ (1α(OH)D~3~) in vivo were studied with a human osteosarcoma cell line (OST strain). Antitumor activity was estimated with the use of 3‐(4,5‐dimethylthiazol)